Literature DB >> 10657563

Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.

C Phillips1, G Murugasu, D Owens, P Collins, A Johnson, G H Tomkin.   

Abstract

Postprandial lipoproteins are raised in diabetes and there is increasing evidence for the atherogenicity of the chylomicron remnant. Increased postprandial cholesteryl ester transfer has also been demonstrated in diabetes and may contribute to the atherogenic lipoprotein profile. The present study examined the effect of improving metabolic control on postprandial lipoproteins in 13 Type 2 diabetic patients. Blood was taken fasting and at 2-h intervals following a high fat, 1100 kcal meal. Patients were brought into good control by intensified dietary advice and oral hyperglycaemic agents or insulin if blood glucose failed to respond. Fasting and postprandial cholesteryl ester transfer protein (CETP) and lecithin:cholesteryl acyltransferase (LCAT) were determined in six patients. Lipoproteins were isolated by sequential ultracentrifugation. Chylomicron and very low density lipoprotein (VLDL) apolipoprotein B-48 and apolipoprotein B-100 were isolated by polyacrylamide gradient gel electrophoresis and quantified by densitometric scanning. CETP and LCAT were determined by an endogenous method which determined cholesterol esterification and transfer between the patients' lipoproteins. There was a significant reduction in postprandial chylomicron apo B-48 (P<0.005), apo B-100 (P<0.0005) and chylomicron cholesterol (P<0.001) following improved diabetic control. The chylomicron lipid/apo B ratio increased with improved control (P<0.01). Postprandial CETP and LCAT were significantly reduced in good control (P<0.01 and P<0.05, respectively) and there were significant changes in HDL composition. The study shows that improvement in metabolic control in Type 2 diabetic patients leads to a reduction in postprandial chylomicron particles and less transfer of cholesterol to apo B-containing lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657563     DOI: 10.1016/s0021-9150(99)00275-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Robert Graves Memorial Lecture. Diabetes and atherosclerosis--a gut review.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

Review 2.  Hyperglycaemia: the relation to dyslipidaemia and atherosclerosis.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

3.  Comparison of diets high in monounsaturated versus polyunsaturated fatty acid on postprandial lipoproteins in diabetes.

Authors:  C Madigan; M Ryan; D Owens; P Collins; G H Tomkin
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

4.  Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors:  M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

5.  Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.

Authors:  Ping Xie; Hongling Zhu; Lin Jia; Yinyan Ma; Weiqing Tang; Youlin Wang; Bingzhong Xue; Hang Shi; Liqing Yu
Journal:  Atherosclerosis       Date:  2014-10-17       Impact factor: 5.162

Review 6.  Recent findings in the study of postprandial lipemia.

Authors:  E J Parks
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

Review 7.  Cholesterol metabolism and therapeutic targets: rationale for targeting multiple metabolic pathways.

Authors:  Stephen D Turley
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

8.  Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein.

Authors:  S Lally; C Y Tan; D Owens; G H Tomkin
Journal:  Diabetologia       Date:  2006-03-04       Impact factor: 10.122

9.  Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases.

Authors:  Boudewijn Klop; Spencer D Proctor; John C Mamo; Kathleen M Botham; Manuel Castro Cabezas
Journal:  Int J Vasc Med       Date:  2011-09-25

Review 10.  Nutrigenetics and metabolic disease: current status and implications for personalised nutrition.

Authors:  Catherine M Phillips
Journal:  Nutrients       Date:  2013-01-10       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.